LPA was found increased in the circulation of Mdr2 KO mice with its levels increasing significantly at the transition from a premalignant to a malignant phenotype, while combined pharmacological inhibition of ATX and LPAR1 reduced HCC growth [239]. This evidence concerns the gene ABCB4 and hepatocellular carcinoma.